Active — Not RecruitingNot Applicable

Strenght Training in Osteoporosis Prevention

Poland120 participantsStarted 2024-09-02

Plain-language summary

The study involves 120 women over the age of 50. All participants in the study take part in high-intensity strength training for 10 months. In addition, half of the participants receive vitamin D3 at a dose of 4,000 IU/day. The investigators hypothesize that training combined with vitamin D3 supplementation will be more effective in preventing osteoporosis than training alone.

Who can participate

Age range50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age over 50 * female Exclusion Criteria: * ongoing cancer, * unstabilized cardiovascular disease, * cognitive disorders, * radiological treatment in the last 12 months, * other contraindications to undertaking high-intensity strength training, * diseases affecting the skeleton such as: Paget's disease, type I diabetes mellitus, * taking medications affecting skeletal conditions including: long-term therapy with corticosteroids, thiazides, antiretroviral drugs, * contraindications to taking vitamin D including: hypercalcemia, nephrolithiasis, sarcoidosis, lack of cholecalciferol hydroxylase activity in the liver and kidneys.

What they're measuring

Bone Mineral Density

Timeframe: Measured at 3 time points: before the experiment, after 10 months of training, and at 6 months after the end of training and supplementation.

Trial details

NCT IDNCT06733064

SponsorMateusz Karnia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-30

View on ClinicalTrials.gov More Osteopenia or Osteoporosis trials